SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-20-002546
Filing Date
2020-10-07
Accepted
2020-10-06 19:28:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13da112566dug_10062020.htm SC 13D/A 44156
2 ex991to13da112566dug_100620.htm EX-99.1 105684
  Complete submission text file 0000921895-20-002546.txt   151303
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Filed by) CIK: 0001055919 (see all company filings)

Type: SC 13D/A

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Subject) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88759 | Film No.: 201227848
SIC: 2834 Pharmaceutical Preparations